RE2 A Detailed Comparison of Dutch and Swedish Drug Reimbursement Decisions: What Evidence is Available, Which Criteria are Used, and is the Decision-Making Process Transparent?
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2012 |
Reihe/Periodikum: | Value in Health ; volume 15, issue 7, page A287 ; ISSN 1098-3015 |
Verlag/Hrsg.: |
Elsevier BV
|
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28580061 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://dx.doi.org/10.1016/j.jval.2012.08.534 |